Skip to main content
Erschienen in: Clinical Rheumatology 1/2012

01.01.2012 | Original Article

Relationship between psoriatic arthritis and moderate–severe psoriasis: analysis of a series of 166 psoriatic arthritis patients selected from a hospital population

verfasst von: Noemi Busquets-Pérez, Jesus Rodriguez-Moreno, Carmen Gómez-Vaquero, Joan M. Nolla-Solé

Erschienen in: Clinical Rheumatology | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

The aim of the study was to assess the prevalence of moderate to severe psoriasis (MS-P) in patients with psoriatic arthritis (PsA) and the relationship between MS-P and other variables related to arthritis. One hundred sixty-six consecutive patients with PsA periodically monitored at a university hospital’s PsA unit in northeastern Spain were included in the study. Patients with psoriasis were classified as having MS-P when systemic treatment for skin was required. Clinical criteria for treatment indication was BSA >10 and/or PASI >14 and/or psoriasis affecting a very sensitive area of the body. Demographic and clinical data related to arthritis were assessed, including PsA pattern, age of onset of psoriasis and arthritis, disease activity index, and treatment required over the course of the disease. Moderate–severe psoriasis were more prevalent in women (p = 0.027). One hundred nine patients (65.7%) had psoriatic nail disease, and MS-P was more frequent in these patients (40 (77%) vs. 69 (61%), p = 0.028). Patients with spondyloarthropathy were significantly associated with MS-P (7 (16%) vs. 3 (3%), p = 0.014). No statistical association was observed between severe psoriasis and the age of onset of psoriasis or arthritis, involvement of distal interphalangeal joints, laboratory findings (HLA B27, RF), functional class, or disease activity indices. We report a high prevalence of severe psoriasis among patients with psoriatic arthritis, higher in women and patients with psoriatic nail disease and axial spondyloarthropathy.
Literatur
1.
Zurück zum Zitat Gladman DD, Antoni C, Mease P, Clegg DO, Nash P (2005) Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 64(Suppl 2):ii14–ii17PubMedCrossRef Gladman DD, Antoni C, Mease P, Clegg DO, Nash P (2005) Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 64(Suppl 2):ii14–ii17PubMedCrossRef
2.
Zurück zum Zitat Little H, Harvie JN, Lester RS (1975) Psoriatic arthritis in severe psoriasis. Can Med Assoc J 112:317–319PubMed Little H, Harvie JN, Lester RS (1975) Psoriatic arthritis in severe psoriasis. Can Med Assoc J 112:317–319PubMed
3.
Zurück zum Zitat Reich K, Kruger K, Mossner R, Augustin M (2009) Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br J Dermatol 160:1040–1047PubMedCrossRef Reich K, Kruger K, Mossner R, Augustin M (2009) Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br J Dermatol 160:1040–1047PubMedCrossRef
4.
Zurück zum Zitat Taylor W, Gladman D, Helliwell P, Marchesoni A, Marchesoni P, Mielants H, CASPARStudy Group (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54(8):2665–2673PubMedCrossRef Taylor W, Gladman D, Helliwell P, Marchesoni A, Marchesoni P, Mielants H, CASPARStudy Group (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54(8):2665–2673PubMedCrossRef
5.
Zurück zum Zitat Prevoo ML, ‘t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48PubMedCrossRef Prevoo ML, ‘t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48PubMedCrossRef
6.
Zurück zum Zitat Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286–2291PubMed Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286–2291PubMed
7.
Zurück zum Zitat Husted JA, Gladman DD, Long JA, Farewell VT (1995) A modified version of the Health Assessment Questionnaire (HAQ) for psoriatic arthritis. Clin Exp Rheumatol 13:439–443PubMed Husted JA, Gladman DD, Long JA, Farewell VT (1995) A modified version of the Health Assessment Questionnaire (HAQ) for psoriatic arthritis. Clin Exp Rheumatol 13:439–443PubMed
8.
Zurück zum Zitat Calin A, Garrett S, Whitelock H, Kennedy LG, O’Hea J, Mallorie P et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281–2285PubMed Calin A, Garrett S, Whitelock H, Kennedy LG, O’Hea J, Mallorie P et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281–2285PubMed
9.
Zurück zum Zitat Fredriksson T, Pettersson U (1978) Severe psoriasis—oral therapy with a new retinoid. Dermatologica 157:238–244PubMedCrossRef Fredriksson T, Pettersson U (1978) Severe psoriasis—oral therapy with a new retinoid. Dermatologica 157:238–244PubMedCrossRef
10.
Zurück zum Zitat Puig L, Carrascosa JM, Dauden E, Sanchez-Carazo JL, Ferrandiz C, Sanchez-Regana M et al (2009) Spanish evidence-based guidelines on the treatment of moderate-to-severe psoriasis with biologic agents. Actas Dermosifiliogr 100:386–413PubMedCrossRef Puig L, Carrascosa JM, Dauden E, Sanchez-Carazo JL, Ferrandiz C, Sanchez-Regana M et al (2009) Spanish evidence-based guidelines on the treatment of moderate-to-severe psoriasis with biologic agents. Actas Dermosifiliogr 100:386–413PubMedCrossRef
11.
Zurück zum Zitat Gelfand JM, Gladman DD, Mease PJ, Smith N, Margolis DJ, Nijsten T et al (2005) Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 53:573PubMedCrossRef Gelfand JM, Gladman DD, Mease PJ, Smith N, Margolis DJ, Nijsten T et al (2005) Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 53:573PubMedCrossRef
12.
Zurück zum Zitat Scarpa R, Oriente P, Pucino A, Torella M, Vignone L, Riccio A et al (1984) Psoriatic arthritis in psoriatic patients. Br J Rheumatol 23:246–250PubMedCrossRef Scarpa R, Oriente P, Pucino A, Torella M, Vignone L, Riccio A et al (1984) Psoriatic arthritis in psoriatic patients. Br J Rheumatol 23:246–250PubMedCrossRef
13.
Zurück zum Zitat Stern RS (1985) The epidemiology of joint complaints in patients with psoriasis. J Rheumatol 12:315–320PubMed Stern RS (1985) The epidemiology of joint complaints in patients with psoriasis. J Rheumatol 12:315–320PubMed
14.
Zurück zum Zitat Leczinsky CG (1948) The incidence of arthropathy in a 10 year series of psoriasis cases. Acta Derm Venereol 28:483–487PubMed Leczinsky CG (1948) The incidence of arthropathy in a 10 year series of psoriasis cases. Acta Derm Venereol 28:483–487PubMed
15.
Zurück zum Zitat Cohen MR, Reda DJ, Clegg DO (1999) Baseline relationships between psoriasis and psoriatic arthritis: analysis of 221 patients with active psoriatic arthritis. Department of Veterans Affairs Cooperative Study Group on Seronegative Spondyloarthropathies. J Rheumatol 26:1752–1756PubMed Cohen MR, Reda DJ, Clegg DO (1999) Baseline relationships between psoriasis and psoriatic arthritis: analysis of 221 patients with active psoriatic arthritis. Department of Veterans Affairs Cooperative Study Group on Seronegative Spondyloarthropathies. J Rheumatol 26:1752–1756PubMed
16.
Zurück zum Zitat Wright V, Roberts MC, Hill AG (1979) Dermatological manifestations in psoriatic arthritis: a follow-up study. Acta Derm Venereol 59:235–240PubMed Wright V, Roberts MC, Hill AG (1979) Dermatological manifestations in psoriatic arthritis: a follow-up study. Acta Derm Venereol 59:235–240PubMed
17.
Zurück zum Zitat Williamson L, Dalbeth N, Dockerty JL, Gee BC, Weatherall R, Wordsworth BP (2004) Extended report: nail disease in psoriatic arthritis–clinically important, potentially treatable and often overlooked. Rheumatology (Oxford) 43:790–794CrossRef Williamson L, Dalbeth N, Dockerty JL, Gee BC, Weatherall R, Wordsworth BP (2004) Extended report: nail disease in psoriatic arthritis–clinically important, potentially treatable and often overlooked. Rheumatology (Oxford) 43:790–794CrossRef
18.
Zurück zum Zitat Jones SM, Armas JB, Cohen MG, Lovell CR, Evison G, McHugh NJ (1994) Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease. Br J Rheumatol 33:834–839PubMedCrossRef Jones SM, Armas JB, Cohen MG, Lovell CR, Evison G, McHugh NJ (1994) Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease. Br J Rheumatol 33:834–839PubMedCrossRef
19.
Zurück zum Zitat Scarpa R, Soscia E, Peluso R, Atteno M, Manguso F, Del Puente A et al (2006) Nail and distal interphalangeal joint in psoriatic arthritis. J Rheumatol 33:1315–1319PubMed Scarpa R, Soscia E, Peluso R, Atteno M, Manguso F, Del Puente A et al (2006) Nail and distal interphalangeal joint in psoriatic arthritis. J Rheumatol 33:1315–1319PubMed
20.
Zurück zum Zitat Barraclough D, Russell AS, Percy JS (1977) Psoriatic spondylitis: a clinical, radiological, and scintiscan survey. J Rheumatol 4:282–287PubMed Barraclough D, Russell AS, Percy JS (1977) Psoriatic spondylitis: a clinical, radiological, and scintiscan survey. J Rheumatol 4:282–287PubMed
21.
Zurück zum Zitat Reina SD, del Blanco J, Bonet M, Castano C, Clavaguera T, Mateo L et al (2007) Functional impairment in psoriatic arthritis. Multicentric study of 343 patients. Med Clin (Barc) 129:201–204CrossRef Reina SD, del Blanco J, Bonet M, Castano C, Clavaguera T, Mateo L et al (2007) Functional impairment in psoriatic arthritis. Multicentric study of 343 patients. Med Clin (Barc) 129:201–204CrossRef
Metadaten
Titel
Relationship between psoriatic arthritis and moderate–severe psoriasis: analysis of a series of 166 psoriatic arthritis patients selected from a hospital population
verfasst von
Noemi Busquets-Pérez
Jesus Rodriguez-Moreno
Carmen Gómez-Vaquero
Joan M. Nolla-Solé
Publikationsdatum
01.01.2012
Verlag
Springer-Verlag
Erschienen in
Clinical Rheumatology / Ausgabe 1/2012
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-011-1787-1

Weitere Artikel der Ausgabe 1/2012

Clinical Rheumatology 1/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.